After transfer, numbers of human CD45+ peripheral blood leucocytes from RTX-treated patients were significantly lower than those observed in mice transferred with cells from SSc patients not treated with RTX (Figure 5B). This evidence concerns the gene PTPRC and systemic sclerosis.